Bristol Myers Squibb Impact Investors
Bristol Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals.
Invests into
.png)
Founded Date:
1887-01-01
Technology:
Biotechnology, Health Care, Medical, Pharmaceutical
Investor Type:
Technology - oriented Investor with Venture Investment Focus
Funding Status:
Post-IPO Debt
Total Funding:
6080000000
Employee Number:
10001+
Headquarters:
New York, New York, United States
Last Funding Date:
2022-02-15
Investors Number:
13
Last Funding Type:
Post-IPO Debt
Estimated Revenue:
$1B to $10B
Investment Stage:
Early Stage Venture, Venture
Acquisitions Number:
Made Acquisitions
Number Of Exists:
11
Industry:
Longevity Biomarkers